Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K

Slides:

Advertisements

Similar presentations

Outcomes of endovascular lower extremity interventions depend more on indication than physician specialty Justin R. Wallace, MD, MSc, Theodore Yuo, MD,

Advertisements

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Outcomes of endovascular lower extremity interventions depend more on indication than physician specialty Justin R. Wallace, MD, MSc, Theodore Yuo, MD,

Endovascular therapy for acute limb ischemia

Autologous alternative veins may not provide better outcomes than prosthetic conduits for below-knee bypass when great saphenous vein is unavailable

Girma Tefera, MD, Charles W. Acher, MD, John R

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Endovascular repair of abdominal aortic aneurysm in octogenarians: An analysis based on EUROSTAR data Conrad Lange, MD, Lina J. Leurs, MSc, Jaap Buth,

Prior endovascular abdominal aortic aneurysm repair provides no survival benefits when the aneurysm ruptures Jae-Sung Cho, MD, Taeyoung Park, PhD, Jang.

Contemporary results of open repair of ruptured descending thoracic and thoracoabdominal aortic aneurysms Joel E. Barbato, MD, Jang Yong Kim, MD, Mazen.

Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia Raymond E. Eid, MD, Li Wang, MS, Michael Kuzman,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal.

Early duplex scanning after infrainguinal endovascular therapy

Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair Athanasios Saratzis, MBBS, MRCS,

Long-term outcomes of internal carotid artery dissection

Prosthetic lower extremity hemodialysis access grafts have satisfactory patency despite a high incidence of infection Irma L. Geenen, MD, Lydia Nyilas,

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Endovascular abdominal aortic aneurysm repair: Long-term outcome measures in patients at high-risk for open surgery Gregorio A. Sicard, MD, Robert M.

One-year pivotal trial outcomes of the Nellix system for endovascular aneurysm sealing Jeffrey P. Carpenter, MD, Robert Cuff, MD, Clifford Buckley, MD,

Durability and survival are similar after elective endovascular and open repair of abdominal aortic aneurysms in younger patients Kevin Lee, MD, Elaine.

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Cost per day of patency: Understanding the impact of patency and reintervention in a sustainable model of healthcare Michael C. Stoner, MD, Dorian J.

Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia Yoshimitsu Soga, MD, Osamu Iida,

Is abdominal aortic aneurysm repair appropriate in oxygen-dependent chronic obstructive pulmonary disease patients? Christopher N. Compton, MD, Ellen.

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Durability of open popliteal artery aneurysm repair

The best of times, the worst of times…

Fenestrated and branched endovascular aneurysm repair outcomes for type II and III thoracoabdominal aortic aneurysms Matthew J. Eagleton, MD, Matthew.

Contemporary results of open repair of ruptured abdominal aortoiliac aneurysms: Effect of surgeon volume on mortality Jae-Sung Cho, MD, Jang Yong Kim,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Katelynn M. Ferranti, MD, Turner M. Osler, MD, Reshma P

Michael P. Harlander-Locke, BS, Liv K. Harmon, MD, Peter F

Christopher J. Smolock, MD, Javier E

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Outcomes of reinterventions after subintimal angioplasty

Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions Gautam V. Shrikhande, MD,

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Daniel J. Torrent, MD, MPH, Jill N. Zink, MD, William M. Bogey, MD, C

No major difference in outcomes for endovascular aneurysm repair stent grafts placed outside of instructions for use William E. Beckerman, MD, Rami O.

Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure Vincent J. Santo, MD, Phong.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative Jeffrey J. Siracuse, MD, Matthew.

Andre Biuckians, MD, MPH, Eric C. Scott, MD, George H

Karthikeshwar Kasirajan, MD, Mark D. Morasch, MD, Michel S

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Melanie R. Hoehn, MD, Ryan M. McEnaney, MD, Theodore H

Cryoplasty Offers No Advantage Over Standard Balloon Angioplasty for the Treatment of In-Stent Restenosis Susanna H. Shin, Donald Baril, Rabih Chaer,

Rabih A. Chaer, MD, Joel E. Barbato, MD, Stephanie C

The Society for Vascular Surgery's objective performance goals for lower extremity revascularization are not generalizable to many open surgical bypass.

Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts. A EUROSTAR report Roel Hobo, MSc, Jacob Buth,

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Consequences of hypogastric artery ligation, embolization, or coverage

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

Reply Journal of Vascular Surgery

Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: An alternative in patients with contraindications to thrombolysis Atul S. Rao,

One-year multicenter results of 100 abdominal aortic aneurysm patients treated with the Endurant stent graft Jasper W. van Keulen, MD, Jean-Paul P.M.

Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era Evan J. Ryer, MD,

Midterm outcomes of the Zenith Renu AAA Ancillary Graft

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Endovascular interventions for TASC II D femoropopliteal lesions

Theodore H. Yuo, MD, MS, Joseph Sidaoui, MD, Luke K

J. David Neel, MD, Robin L. Kruse, PhD, Viktor Y

Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation Theodore.

Delayed open conversions after endovascular abdominal aortic aneurysm repair Cassius Iyad Ochoa Chaar, MD, Raymond Eid, MD, Taeyoung Park, PhD, Robert.

Isolated femoral endarterectomy: Impact of SFA TASC classification on recurrence of symptoms and need for additional intervention Georges Al-Khoury,

Hybrid surgery for bilateral lower extremity inflow revascularization

Presentation transcript:

Impact of endovascular options on lower extremity revascularization in young patients Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K. Marone, MD, Robert Y. Rhee, MD, George Al-Khoury, MD, Jae S. Cho, MD, Steven A. Leers, MD, Rabih A. Chaer, MD Journal of Vascular Surgery Volume 56, Issue 3, Pages 703-713.e3 (September 2012) DOI: 10.1016/j.jvs.2012.01.073 Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 1 Kaplan-Meier curves show 2-year primary patency for patients in groups A (blue line), B (black line), and C (red line). Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 2 Kaplan-Meier curves show 2-year primary patency for patients in groups A (blue line), B (black line), and C (red line) treated for claudication. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier curves show 2-year primary patency for patients in groups A (blue line), B (black line), and C (red line) treated with an endovascular procedure. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 4 Kaplan-Meier curves show 2-year freedom from major amputation for patients in groups A (blue line), B (black line), and C (red line) treated with an endovascular procedure. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 5 Freedom from reintervention at 2 years is shown for patients in groups A (blue line), B (black line), and C (red line). Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 6 Survival at 3 years is shown for patients in groups A (blue line), B (black line), and C (red line). Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Supplementary Fig 1 (online only) Kaplan-Meier curves show 2-year primary assisted patency for patients in groups A (blue line), B (black line), and C (red line). Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Supplementary Fig 2 (online only) Kaplan-Meier curves show 2-year secondary patency for patients in groups A (blue line), B (black line), and C (red line). Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Supplementary Fig 3 (online only) Kaplan-Meier curves show 2-year primary assisted patency for patients in groups A (blue line), B (black line), and C (red line) treated for claudication. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Supplementary Fig 4 (online only) Kaplan-Meier curves show 2-year secondary patency for patients in groups A (blue line), B (black line), and C (red line) treated for claudication. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Supplementary Fig 5 (online only) Kaplan-Meier curves show 2-year primary assisted patency for patients in groups A (blue line), B (black line), and C (red line) treated with endovascular procedures. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Supplementary Fig 6 (online only) Kaplan-Meier curves show 2-year secondary patency for patients in groups A (blue line), B (black line), and C (red line) treated with endovascular procedures. Journal of Vascular Surgery 2012 56, 703-713.e3DOI: (10.1016/j.jvs.2012.01.073) Copyright © 2012 Society for Vascular Surgery Terms and Conditions